The Johns Hopkins Graduate Training Program in Clinical Investigation (GTPCI) was initiated in 1993 as a joint effort of the University's Schools of Medicine and Public Health. The Program has matriculated 45 physician-investigators over five years into a year-long didactic curriculum which is then followed by at least two years of mentored clinical research leading to thesis publication and the award of either an M.Sc. or Ph.D. degree. We now propose under this new NIH support mechanism to provide enhanced administrative, mentoring, and curriculum structures for this model program, and to evaluate its success in generating productive career investigators. New features include expansion of curriculum elements, including Web-based learning, extension of the core curriculum to a broader audience including faculty and postdoctoral fellows, formal appraisal of educational outcomes, enhancement of minority recruitment and trainee retention, and enrichment experiences in clinical investigation for faculty and the entire academic community. The long-term objective of this project is to strengthen, enhance, and evaluate a model for training superior clinical investigators, with which we already have gained considerable experience, and to extend some of its benefits to a broader group of clinical investigators both within and external to Johns Hopkins.
The specific aims are: (1) to provide and enhance an administrative and curriculum structure for the ongoing GTPCI; (2) to evaluate the success of the GTPCI model and related programs in generating successful career investigators; and (3) to provide shorter term curricula in aspects of clinical investigation to a broader group of postdoctoral fellows, faculty and active clinical investigators both within and external to Johns Hopkins. We expect that these enhancements and extensions will heighten the visibility, effectiveness and success of future careers in clinical investigation at our institution.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Clinical Research Curriculum Award (CRCA) (K30)
Project #
5K30HL004137-02
Application #
6183667
Study Section
Special Emphasis Panel (ZHL1-CSR-F (M2))
Project Start
1999-06-01
Project End
2004-05-31
Budget Start
2000-06-01
Budget End
2001-05-31
Support Year
2
Fiscal Year
2000
Total Cost
$200,000
Indirect Cost
Name
University of Texas Health Science Center Houston
Department
Pediatrics
Type
Schools of Medicine
DUNS #
City
Houston
State
TX
Country
United States
Zip Code
77225
Skinner, Heath D; Hong, Theodore S; Krishnan, Sunil (2011) Charged-particle therapy for hepatocellular carcinoma. Semin Radiat Oncol 21:278-86
Krishnan, Sunil; Diagaradjane, Parmeswaran; Cho, Sang Hyun (2010) Nanoparticle-mediated thermal therapy: evolving strategies for prostate cancer therapy. Int J Hyperthermia 26:775-89
Checker, Rahul; Sharma, Deepak; Sandur, Santosh K et al. (2010) Plumbagin inhibits proliferative and inflammatory responses of T cells independent of ROS generation but by modulating intracellular thiols. J Cell Biochem 110:1082-93
Deorukhkar, Amit; Krishnan, Sunil (2010) Targeting inflammatory pathways for tumor radiosensitization. Biochem Pharmacol 80:1904-14
Silberfein, Eric J; Kattepogu, Kiran M; Hu, Chung-Yuan et al. (2010) Long-term survival and recurrence outcomes following surgery for distal rectal cancer. Ann Surg Oncol 17:2863-9
Harikumar, Kuzhuvelil B; Kunnumakkara, Ajaikumar B; Sethi, Gautam et al. (2010) Resveratrol, a multitargeted agent, can enhance antitumor activity of gemcitabine in vitro and in orthotopic mouse model of human pancreatic cancer. Int J Cancer 127:257-68
Sharma, Deepak; Sandur, Santosh K; Rashmi, R et al. (2010) Differential activation of NF-*B and nitric oxide in lymphocytes regulates in vitro and in vivo radiosensitivity. Mutat Res 703:149-57
Diagaradjane, Parmeswaran; Deorukhkar, Amit; Gelovani, Juri G et al. (2010) Gadolinium chloride augments tumor-specific imaging of targeted quantum dots in vivo. ACS Nano 4:4131-41